Suvretta Capital Management
$3.7B Assets Reported
105 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 12,327,000 | $290M | 7.9% |
| MANE | VERADERMICS INC | 4,168,970 | $263M | 7.1% |
| PVLA | PALVELLA THERAPEUTICS INC NE | 1,153,496 | $144M | 3.9% |
| APLS | APELLIS PHARMACEUTICALS INC | 3,518,471 | $142M | 3.8% |
| LEGN | LEGEND BIOTECH CORP | 7,581,029 | $137M | 3.7% |
| BNTC | BENITEC BIOPHARMA INC | 11,548,351 | $123M | 3.3% |
| CAPR | CAPRICOR THERAPEUTICS INC | 3,818,600 | $116M | 3.1% |
| IMTX | IMMATICS N.V | 11,190,129 | $110M | 3.0% |
| RCUS | ARCUS BIOSCIENCES INC | 5,030,993 | $109M | 2.9% |
| EYPT | EYEPOINT INC | 8,296,375 | $107M | 2.9% |
Track Suvretta Capital Management's 13F portfolio: $3.7B in reported holdings, 105 positions. Top holdings, AUM, and quarterly changes on SentiSense.